In a report released on November 7, Ashish Sabadra from RBC Capital maintained a Hold rating on Clarivate (CLVT – Research Report), with a price target of $8.00. The company’s shares closed yesterday at $6.88.
According to TipRanks, Sabadra is a 2-star analyst with an average return of 0.0% and a 46.95% success rate. Sabadra covers the Financial sector, focusing on stocks such as Automatic Data Processing, Moody’s, and Equifax.
Currently, the analyst consensus on Clarivate is a Moderate Buy with an average price target of $8.50.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $11.99 and a one-year low of $6.07. Currently, Clarivate has an average volume of 6.01M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Clarivate (CLVT) Company Description:
Clarivate Analytics Plc provides trusted insights and analytics to accelerate the pace of innovation. Its solutions include scientific and research, patent intelligence and compliance standards, pharmaceutical and biotech intelligence and trademark, domain and brand protection. The company product portfolio includes Life Science, Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor and Techstreet. It helps clients to reduce the time from new ideas to life changing innovations. The company was founded in 1864 and is headquartered in St. Helier, Jersey.
Read More on CLVT:
